These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 6133664)

  • 21. [Comparative pharmacokinetics of 5 hypnotic benzodiazepines in healthy volunteers].
    Jochemsen R; Van Boxtel CJ; Breimer DD
    Nouv Presse Med; 1982 Oct; 11(40):2965-6. PubMed ID: 6128720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
    Masica AL; Mayo G; Wilkinson GR
    Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacokinetics of midazolam and loprazolam in healthy subjects after oral administration.
    Jochemsen R; van Rijn PA; Hazelzet TG; van Boxtel CJ; Breimer DD
    Biopharm Drug Dispos; 1986; 7(1):53-61. PubMed ID: 2869795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam.
    Smith RB; Divoll M; Gillespie WR; Greenblatt DJ
    J Clin Psychopharmacol; 1983 Jun; 3(3):172-6. PubMed ID: 6135721
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of temazepam compared with other benzodiazepine hypnotics--some clinical consequences.
    Jochemsen R; Breimer DD
    Acta Psychiatr Scand Suppl; 1986; 332():20-31. PubMed ID: 2883825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is temazepam an accumulating hypnotic?
    Ochs HR; Greenblatt DJ; Heuer H
    J Clin Pharmacol; 1984 Jan; 24(1):58-64. PubMed ID: 6142905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.
    Yuan R; Flockhart DA; Balian JD
    J Clin Pharmacol; 1999 Nov; 39(11):1109-25. PubMed ID: 10579141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of pharmacokinetic findings for the clinical effect of benzodiazepines].
    Horowski R; Dorow R
    Internist (Berl); 1982 Nov; 23(11):632-40. PubMed ID: 6130052
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple-dose halazepam kinetics.
    Chung M; Hilbert JM; Gural RP; Radwanski E; Symchowicz S; Zampaglione N
    Clin Pharmacol Ther; 1984 Jun; 35(6):838-42. PubMed ID: 6145534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and the sedative effect of midazolam.
    Kanto J; Allonen H
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):460-3. PubMed ID: 6138314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures.
    Horowski R
    J Neural Transm (Vienna); 2020 Aug; 127(8):1107-1115. PubMed ID: 32468272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative bioavailability in humans for oral tablets and solutions of lormetazepam.
    Zecca L; Reina L; Scaglione F; Ferrario P; Pirola R; Ceccarelli G; Ciampini M; Fraschini F
    Arzneimittelforschung; 1985; 35(12):1870-2. PubMed ID: 2869762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. III. Repeated administration and transfer to neonates via breast milk.
    Seyberth HW
    Eur J Clin Pharmacol; 1983; 24(1):139-40. PubMed ID: 6131824
    [No Abstract]   [Full Text] [Related]  

  • 34. [Screening, detection and biotransformation of lormetazepam, a new hypnotic agent from the 1,4-benzodiazepine series (author's transl)].
    Schütz H; Fitz H
    Arzneimittelforschung; 1982; 32(3):177-83. PubMed ID: 6123328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam.
    Ellinwood EH; Heatherly DG; Nikaido AM; Bjornsson TD; Kilts C
    Psychopharmacology (Berl); 1985; 86(4):392-9. PubMed ID: 2863843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral benzodiazepines and conscious sedation: a review.
    Loeffler PM
    J Oral Maxillofac Surg; 1992 Sep; 50(9):989-97. PubMed ID: 1354722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interaction of the hypnotic lormetazepam with central benzodiazepine receptor subtypes omega 1, omega 2 and omega 3].
    Ozawa M; Nakada Y; Sugimachi K; Akai T; Yamaguchi M
    Nihon Yakurigaku Zasshi; 1991 Nov; 98(5):399-408. PubMed ID: 1687574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzodiazepines: a summary of pharmacokinetic properties.
    Greenblatt DJ; Shader RI; Divoll M; Harmatz JS
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):11S-16S. PubMed ID: 6133528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two more hypnotics added to the 'White List'.
    Drug Ther Bull; 1987 Jun; 25(11):43-4. PubMed ID: 2885165
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of the hypnotic benzodiazepine, temazepam.
    Bittencourt P; Richens A; Toseland PA; Wicks JF; Latham AN
    Br J Clin Pharmacol; 1979; 8(1):37S-38S. PubMed ID: 41541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.